Adalta Capital Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
BCM
TWM
EFG
AFWM
PFA
QA
Adalta Capital Management's BTAL Position: Q4 2022 in Review
Adalta Capital Management sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2022, closing a stake of 15,500 shares — an estimated $315K sold.
Adalta Capital Management first reported a position in BTAL in Q1 2020 and held it in 6 quarters. The position peaked at $2.49M in Q3 2020. 80 funds tracked by Wall St. Rank hold BTAL as of Q4 2022.
- Adalta Capital Management reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2022 after selling out during the quarter.
- Adalta Capital Management sold 15,500 AGF US Market Neutral Anti-Beta Fund shares in Q4 2022, an estimated $315K.
- Adalta Capital Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2020 and held it in 6 quarters.
- Adalta Capital Management's AGF US Market Neutral Anti-Beta Fund position peaked at $2.49M in Q3 2020.
- 80 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2022.
Based on Adalta Capital Management's 13F filing for Q4 2022, filed 21 Feb 2023.